• 58-year-old woman with fatigue, adynamia and night sweat
• A case of hyperkalemic periodic paralysis presenting progressive myopathy with tubular aggregates
• A Case of Hypokalemic Periodic Paralysis in a Young Athlete
• A case of myotonic dystrophy with electrolyte imbalance
• A dangerous food binge: a case report of hypokalemic periodic paralysis and review of current literature
• A new clinical entity in T704M mutation in periodic paralysis
• A novel Kir2.6 mutation associated with hypokalemic periodic paralysis
• A role for external Ca2+ in maintaining muscle contractility in periodic paralysis
• A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant
• A Thyrotoxic Periodic Paralysis Case Study: From Weakness to Wellness
• A zebrafish model of nondystrophic myotonia with sodium channelopathy
• Accuracy of preimplantation genetic diagnosis in equine in vivo-recovered and in vitro-produced blastocysts
• Acquired hyperkalaemia leading to periodic paralysis: an emergency department perspective
• Acute generalized weakness in patients referred to Amirkola Children's Hospital from 2005 to 2010
• Allele frequency of muscular genetic disorders in bull-catching (vaquejada) quarter horses
• ANESTHESIA CHARACTERISTICS OF A PATIENT WITH HYPERKALEMIC PERIODIC PARALYSIS--CASE REPORT
• Anesthetic Management in Familial Hyperkalemic Periodic Paralysis: A Case Report
• BK channel openers NS1619 and NS11021 reverse hydrogen peroxide-induced membrane potential changes in skeletal muscle
• Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis
• Channelopathies
• Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals
• Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations
• Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis
• Contractile abnormalities of mouse muscles expressing hyperkalemic periodic paralysis mutant NaV1.4 channels do not correlate with Na+ influx or channel content
• Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome
• Dichlorphenamide (Keveyis) for periodic paralysis
• Dichlorphenamide for Refractory Hyperkalemic Periodic Paralysis
• Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy
• Effects of S906T polymorphism on the severity of a novel borderline mutation I692M in Na(v) 1.4 cause periodic paralysis
• Effects of S906T polymorphism on the severity of a novel borderline mutation I692M in Na_v 1.4 cause periodic paralysis
• Electrodiagnosis of myotonic disorders
• Episodic Muscle Disorders
• Gene panel analysis of 119 index patients with suspected periodic paralysis in Japan
• Genetic analysis of 37 cases with primary periodic paralysis in Chinese patients
• Hyperkalaemic periodic paralysis in pregnancy
• Hyperkalemic Periodic Paralysis
• Hyperkalemic Periodic Paralysis
• Hyperkalemic periodic paralysis aggravated by voltage - gate sodium channel blocker antiepileptic drug?
• Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4
• Hyperkalemic Periodic Paralysis in Twenty-Two Family Members Over Four Generations: A Rare Case Report
• Hyperkalemic Periodic Paralysis Secondary to End-Stage Renal Disease and Excess Potato Consumption
• Hyperkalemic periodic paralysis with paramyotonia and the anaesthetic implications
• Hyperkalemic Periodic Paralysis: Case Report with a SCNA4 Gene Mutation and Literature Review
• Hypokalemic paralysis as an initial presentation of Sjogren syndrome
• Hypokalemic periodic paralysis. A case report
• In vivo assessment of interictal sarcolemmal membrane properties in hypokalaemic and hyperkalaemic periodic paralysis
• Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis
• Long-term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis
• Louis Ptáček receives the 2015 ASCI/Stanley J. Korsmeyer Award. Interview by Sarah Jackson
• Lower Ca2+ enhances the K+-induced force depression in normal and HyperKPP mouse muscles
• Lower-extremity magnetic resonance imaging in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: 30-month follow-up of seven patients
• Muscle channelopathies
• Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation
• Mutation spectrum and health status in skeletal muscle channelopathies in Japan
• Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes
• Mutations in SCN4A: a rare but treatable cause of recurrent life-threatening laryngospasm
• Mutations of SCN4A gene cause different diseases: 2 case reports and literature review
• Myotonic disorders: A review article
• Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C&gt;G, p.L769V Mutation in <em>SCN4A</em>
• N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis
• Normokalemic periodic paralysis lasting for two weeks: a severe form of sodium channelopathy with M1592V mutation
• Overlap of periodic paralysis and paramyotonia congenita caused by SCN4A gene mutations two family reports and literature review
• Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses
• Pediatric neuromuscular channelopathies
• Periodic paralysis
• Periodic paralysis due to cumulative effects of rare variants in SCN4A with small functional alterations
• Periodic Paralysis Syndromes: A T3 Thyrotoxicosis Case and Review of Literature
• Phenotypic heterogeneity in skeletal muscle sodium channelopathies: A case report and literature review
• Physiological basis for muscle stiffness and weakness in a knock-in M1592V mouse model of hyperkalemic periodic paralysis
• Post-exercise increment in compound muscle action potential amplitude in hyperkalemic periodic paralysis
• Pregnancy reduces severity and frequency of attacks in hyperkalemic periodic paralysis due to the mutation c.2111C&gt;T in the <em>SCN4A</em> gene
• Pregnancy reduces severity and frequency of attacks in hyperkalemic periodic paralysis due to the mutation c.2111C>T in the SCN4A gene
• Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands
• Prevalence of Genetic Mutations in Horses With Muscle Disease From a Neuromuscular Disease Laboratory
• Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing
• Prevalence of the E321G MYH1 variant for immune-mediated myositis and nonexertional rhabdomyolysis in performance subgroups of American Quarter Horses
• Prevalence study of genetically defined skeletal muscle channelopathies in England
• Primary Periodic Paralyses: A Review of Etiologies and Their Pathogeneses
• Psychopharmacological Treatments for Mental Disorders in Patients with Neuromuscular Diseases: A Scoping Review
• Quantitative sonographic assessment of myotonia
• Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis
• Recovery from acidosis is a robust trigger for loss of force in murine hypokalemic periodic paralysis
• Review of the Diagnosis and Treatment of Periodic Paralysis
• Severe hypokalemic paralysis and rhabdomyolysis occurring after binge eating in a young bodybuilder: Case report
• Sodium Channelopathies of Skeletal Muscle
• Special electromyographic features in a child with paramyotonia congenita: A case report and review of literature
• Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children
• Spider toxin inhibits gating pore currents underlying periodic paralysis
• Sporadic adult-onset brainstem hyperkalemic periodic paralysis masquerading as recurrent transient ischemic attacks
• Substitutions of the S4DIV R2 residue (R1451) in Na(V)1.4 lead to complex forms of paramyotonia congenita and periodic paralyses
• Substitutions of the S4DIV R2 residue (R1451) in Na_V1.4 lead to complex forms of paramyotonia congenita and periodic paralyses
• Successful treatment of normokalemic periodic paralysis with hydrochlorothiazide
• Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine
• The effect of systemic acetazolamide administration on intraocular pressure in healthy horses-A preliminary study
• The Role of Nutrition and Physical Activity as Trigger Factors of Paralytic Attacks in Primary Periodic Paralysis
• Thyroid disease and the nervous system
• Understanding the physiology of the asymptomatic diaphragm of the M1592V hyperkalemic periodic paralysis mouse
• Unusual Clinical Presentation of Periodic Paralysis: Case Report and Literature Review
• Voltage-sensor movements describe slow inactivation of voltage-gated sodium channels II: a periodic paralysis mutation in Na(V)1.4 (L689I)
• Whole-Body Muscle MRI in Patients with Hyperkalemic Periodic Paralysis Carrying the SCN4A Mutation T704M: Evidence for Chronic Progressive Myopathy with Selective Muscle Involvement